PL326364A1 - Method mobilising haematopoetic parent cells - Google Patents

Method mobilising haematopoetic parent cells

Info

Publication number
PL326364A1
PL326364A1 PL96326364A PL32636496A PL326364A1 PL 326364 A1 PL326364 A1 PL 326364A1 PL 96326364 A PL96326364 A PL 96326364A PL 32636496 A PL32636496 A PL 32636496A PL 326364 A1 PL326364 A1 PL 326364A1
Authority
PL
Poland
Prior art keywords
haematopoetic
mobilising
parent cells
parent
cells
Prior art date
Application number
PL96326364A
Other languages
English (en)
Inventor
Louis Martin Pelus
Andrew Garrison King
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of PL326364A1 publication Critical patent/PL326364A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/49—Platelet-derived growth factor [PDGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL96326364A 1995-10-24 1996-10-24 Method mobilising haematopoetic parent cells PL326364A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54726295A 1995-10-24 1995-10-24

Publications (1)

Publication Number Publication Date
PL326364A1 true PL326364A1 (en) 1998-09-14

Family

ID=24183989

Family Applications (1)

Application Number Title Priority Date Filing Date
PL96326364A PL326364A1 (en) 1995-10-24 1996-10-24 Method mobilising haematopoetic parent cells

Country Status (14)

Country Link
EP (1) EP0866806A4 (xx)
JP (1) JPH11512747A (xx)
KR (1) KR19990066997A (xx)
AR (1) AR004093A1 (xx)
AU (1) AU712235B2 (xx)
BR (1) BR9611173A (xx)
CZ (1) CZ120298A3 (xx)
HU (1) HUP9802531A3 (xx)
NO (1) NO981818L (xx)
NZ (1) NZ321789A (xx)
PL (1) PL326364A1 (xx)
TR (1) TR199800742T2 (xx)
WO (1) WO1997015595A1 (xx)
ZA (1) ZA968896B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458349B1 (en) 1995-06-02 2002-10-01 Human Genome Sciences, Inc. Chemokine β-4 polypeptides
US6391589B1 (en) 1994-08-23 2002-05-21 Human Genome Sciences, Inc. Human chemokine beta-10 mutant polypeptides
US6174995B1 (en) 1994-08-23 2001-01-16 Haodong Li Human chemokines, CKβ4 and CKβ10/MCP-4
US6042821A (en) * 1995-11-21 2000-03-28 Smithkline Beecham Corporation Method of treating sepsis with chemokines
US6290948B1 (en) 1996-05-14 2001-09-18 Smithkline Beecham Corporation Method of treating sepsis and ARDS using chamohine beta-10
WO1999026645A1 (en) * 1997-11-26 1999-06-03 Smithkline Beecham Corporation Method of mobilizing hematopoietic stem cells
EP1100916A2 (fr) * 1999-06-08 2001-05-23 Transgene S.A. Composition destinee a la mise en oeuvre d'un traitement cytotoxique, notamment antitumoral ou antiviral, chez un mammifere
EP1303292A4 (en) * 2000-06-30 2007-08-22 Smithkline Beecham Corp CHEMOKINKONJUGATE
JP3563366B2 (ja) * 2001-05-07 2004-09-08 独立行政法人 科学技術振興機構 蛋白質高次構造に対してアンフォールド活性を有する蛋白質多量体
IL146970A0 (en) * 2001-12-06 2002-08-14 Yeda Res & Dev Migration of haematopoietic stem cells and progenitor cells to the liver
US7375192B2 (en) 2002-05-01 2008-05-20 Human Genome Sciences, Inc. Antibodies that specifically bind to chemokine beta-4
AU2011329647B2 (en) 2010-11-19 2015-10-22 Eisai R&D Management Co., Ltd. Neutralizing anti-CCL20 antibodies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0713495B1 (en) * 1993-06-08 2003-11-05 Smithkline Beecham Corporation Methods of enhancing bioactivity of chemokines
GB9426012D0 (en) * 1994-12-22 1995-02-22 British Biotech Pharm Mobilisation of haematopoietic cells
GB9517014D0 (en) * 1995-08-19 1995-10-25 British Biotech Pharm Haematopoietic recovery

Also Published As

Publication number Publication date
JPH11512747A (ja) 1999-11-02
ZA968896B (en) 1997-04-24
NO981818D0 (no) 1998-04-23
AU712235B2 (en) 1999-11-04
EP0866806A4 (en) 2002-01-09
NZ321789A (en) 2000-07-28
AR004093A1 (es) 1998-09-30
HUP9802531A2 (hu) 1999-02-01
WO1997015595A1 (en) 1997-05-01
HUP9802531A3 (en) 2001-08-28
TR199800742T2 (xx) 1998-08-21
MX9803217A (es) 1998-09-30
AU7520996A (en) 1997-05-15
NO981818L (no) 1998-06-17
KR19990066997A (ko) 1999-08-16
EP0866806A1 (en) 1998-09-30
CZ120298A3 (cs) 1998-09-16
BR9611173A (pt) 1999-03-30

Similar Documents

Publication Publication Date Title
IL125126A0 (en) Electroconversion cell
HUP9903761A3 (en) Method for the fabrication of electrochemical cells
IL117721A (en) Spacer flash cell process
SG48975A1 (en) Spacer flash cell process
GB9416334D0 (en) Transesterification process
EP1009855A4 (en) METHOD FOR CELL SEPARATION
PL323178A1 (en) Schirophrenia diagnosin method
SG44995A1 (en) Manufacturing method for polycarbonate
EP0807783A4 (en) COMPOSED CELL STRUCTURE AND METHOD FOR THEIR PRODUCTION
GB9509336D0 (en) Chemical method
PL326364A1 (en) Method mobilising haematopoetic parent cells
GB9518442D0 (en) Method
GB9519638D0 (en) Method
GB2308522B (en) Redialling method
GB9601976D0 (en) Method
ZA959731B (en) Analytical method
GB9510727D0 (en) Method
GB9511828D0 (en) Method
EP0737829A3 (fr) Joint d'étanchéité ainsi que son procédé de fabrication
GB9508129D0 (en) Cell modification
GB9417531D0 (en) Chemical method
GB9519057D0 (en) Method for the fabrication of electrodes
AU2804695A (en) Detection method
GB9415055D0 (en) Analytical method
GB9514713D0 (en) Method